Related references
Note: Only part of the references are listed.Long-Term Outcome and Quality of Life of Patients With Endometrial Carcinoma Treated With or Without Pelvic Radiotherapy in the Post Operative Radiation Therapy in Endometrial Carcinoma 1 (PORTEC-1) Trial
Remi A. Nout et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
ASTEC lymphadenectomy and radiation therapy studies: Are conclusions valid?
W. T. Creasman et al.
GYNECOLOGIC ONCOLOGY (2010)
Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial
R. A. Nout et al.
LANCET (2010)
Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis
Yukiharu Todo et al.
LANCET (2010)
Intermediate-risk endometrial cancer-adjuvant treatment
Patricia J. Eifel
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
Prospective multi-center trial utilizing electronic brachytherapy for the treatment of endometrial cancer
Adam Dickler et al.
RADIATION ONCOLOGY (2010)
Quality of Life After Pelvic Radiotherapy or Vaginal Brachytherapy for Endometrial Cancer: First Results of the Randomized PORTEC-2 Trial
Remi A. Nout et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Survival impact of lymph node dissection in endometrial adenocarcinoma: a surveillance, epidemiology, and end results analysis
D. C. Smith et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2008)
Systematic Pelvic Lymphadenectomy vs No Lymphadenectomy in Early-Stage Endometrial Carcinoma: Randomized Clinical Trial
Pierluigi Benedetti Panici et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
The use of adjuvant radiation therapy in early endometrial cancer by members of the Society of Gynecologic Oncologists in 2005
R. Wendel Naumann et al.
GYNECOLOGIC ONCOLOGY (2007)
Stage II endometrial carcinoma: Limiting post-operative radiotherapy to the vaginal vault in node-negative tumors
PVC Rittenberg et al.
GYNECOLOGIC ONCOLOGY (2005)
Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer
JM Cragun et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients:: The postoperative radiation therapy in endometrial carcinoma trial
CL Creutzberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study
HM Keys et al.
GYNECOLOGIC ONCOLOGY (2004)
Intravaginal high-dose-rate brachytherapy for Stage IB (FIGO Grade 1, 2) endometrial cancer
KM Alektiar et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2002)
The morbidity of treatment for patients with stage I endometrial cancer:: Results from a randomized trial
CL Creutzberg et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2001)
Potential benefit of lymphadenectomy for the treatment of node-negative locally advanced uterine cancers
DP Seago et al.
GYNECOLOGIC ONCOLOGY (2001)
Significant pelvic recurrence in high-risk pathologic stage I-IV endometrial carcinoma patients after adjuvant chemotherapy alone: Implications for adjuvant radiation therapy
AJ Mundt et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2001)
Long-term survival of intermediate risk endometrial cancer (Stage IG3, IC, II) treated with full lymphadenectomy and brachytherapy without teletherapy
J Fanning
GYNECOLOGIC ONCOLOGY (2001)
Postoperative vaginal vault brachytherapy for node-negative stage II (Occult) endometrial carcinoma
TY Ng et al.
GYNECOLOGIC ONCOLOGY (2001)
Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma:: multicentre randomised trial
CL Creutzberg et al.
LANCET (2000)
Share Paper
